α1,2fucosylation is a superior predictor of postoperative prognosis for colorectal cancer compared with blood group A, B, or sialyl lewis X antigen generated within colorectal tumor tissues

Annals of Surgical Oncology

Volumn 14, Issue 6, 2007, Pages 1880-1889

  Tsuboi, Kaori ^a   Asao, Takayuki ^a   Ide, Munenori ^a   Hashimoto, Shinji ^a   Noguchi, Kasumi ^b   Kominato, Yoshihiko ^a   Saniabadi, Abby R ^c   Kuwano, Hiroyuki ^a   Yazawa, Shin ^a,d,e  

^a GUNMA UNIVERSITY   (Japan)

^b Criminal Investigation Laboratory   (Japan)

^c JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

^d OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^e GUNMA UNIVERSITY   (Japan)

Author keywords

1,2Fucosylation; A and B enzyme; Blood group A and B antigens; Colorectal cancer; Diagnosis; Distal colon; Sialyl Lewis X antigen; Survival rate

Indexed keywords

BLOOD GROUP A ANTIBODY; BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIBODY; BLOOD GROUP B ANTIGEN; BLOOD GROUP H ANTIGEN; DISACCHARIDE; GLYCOSYLTRANSFERASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY YB 2; MONOCLONAL ANTIBODY YB 3; PROTEIN ANTIBODY; SIALYL LEWIS X ANTIBODY; SIALYL LEWIS X ANTIGEN; UNCLASSIFIED DRUG; 5 ACETYLNEURAMINYL (2 3) GALACTOSYL (1 4) (FUCOPYRANOSYL (1 3)) N ACETYLGLUCOSAMINE; 5-ACETYLNEURAMINYL-(2-3)-GALACTOSYL-(1-4)-(FUCOPYRANOSYL-(1-3))-N-ACETYLGLUCOSAMINE; CD15 ANTIGEN; DIAGNOSTIC AGENT; FUCOSYL 1 2 GALACTOSE; FUCOSYL-1-2-GALACTOSE; FUCOSYLGALACTOSE ALPHA N ACETYLGALACTOSAMINYLTRANSFERASE; H2 ANTIGEN; OLIGOSACCHARIDE; TUMOR ANTIGEN; TUMOR MARKER;

ANTIGEN RECOGNITION; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; COLORECTAL CANCER; COLORECTAL TUMOR; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ANALYSIS; FEMALE; FUCOSYLATION; HUMAN; HUMAN TISSUE; IMMUNODETECTION; IMMUNOHISTOCHEMISTRY; LARGE INTESTINE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREDICTION; PROGNOSIS; PROTEIN SYNTHESIS; RECTUM; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; BLOOD GROUP ABO SYSTEM; BLOOD GROUP LEWIS SYSTEM; COLON TUMOR; FORECASTING; PATHOLOGY; RECTUM TUMOR;

ABO BLOOD-GROUP SYSTEM; ANTIBODIES, MONOCLONAL; ANTIGENS, CD15; ANTIGENS, NEOPLASM; COLONIC NEOPLASMS; DISACCHARIDES; FEMALE; FORECASTING; FUCOSYL GALACTOSE ALPHA-N-ACETYLGALACTOSAMINYLTRANSFERASE; GLYCOSYLTRANSFERASES; H-2 ANTIGENS; HUMANS; LEWIS BLOOD-GROUP SYSTEM; MALE; OLIGOSACCHARIDES; PROGNOSIS; RECTAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34249874312     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9363-2     Document Type: Article

References (43)

1. Hakomori S. Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochim Biophys Acta 1999;1473:247-66
2. Le Pendu J, Marionneau S, Cailleau-Thomas A, et al. ABH and Lewis histo-blood group antigens in cancer. APMIS 2001;109:9-31
3. Varki A. Glycosylation changes in cancers. In: Varki A, Cummings R, Esko J, Freeze H, Hart G, Marth J, eds. Essentials of Glycobiology, Cold Spring Harbor NY: Cold Spring Harbor Press, 1999;537-49
4. Yazawa S, Nishihara S, Iwasaki H, et al. Genetic and enzymatic evidence for Lewis enzyme expression in Lewis-negative cancer patients. Cancer Res 1995;55:1473-8
5. Nakamura J, Mogi A, Asao T, Nagamachi Y, Yazawa S. Evidence that the aberrant αl→2fucosyltransferase found in colorectal carcinoma may be encoded by Fuc-TIII (Le) gene. Anticancer Res 1997;17:4563-9
6. Ørntoft TF, Greenwell P, Clausen H, Watkins WM. Regulation of the oncodevelopmental expression of type 1 chain ABH and Lewis(b) blood group antigens in human colon by alpha-2-L-fucosylation. Gut 1991;32:287-93
7. Yazawa S, Akamatsu S, Tachikawa T, et al. Development and characterization of a novel anti-fucosylated antigen monoclonal antibody YB-2 and its usefulness in the immunohistochemical diagnosis of colorectal cancer. Jpn J Cancer Res 1993;84:641-8
8. Akamatsu S, Yazawa S, Tachikawa T, et al. α2→ 3sialyltransferase associated with the synthesis of CA 19-9 in colorectal tumors. Cancer 1996;77:1694-700
9. Naitoh H, Nakajima T, Nagamachi Y, Yazawa S. A clinicopathological evaluation of anti-fucosylated antigens antibody (YB-2) in colorectal carcinoma. Glycosylation Dis 1994;1:31-6
10. b and Y antigens in colorectal tumors. Jpn J Cancer Res 1993;84:989-95
11. Yazawa S, Nishimura T, Ide M, et al. Tumor-related expression of α 1,2fucosylated antigens on colorectal carcinoma cells and its suppression by cell-mediated priming using sugar acceptors for α1,2fucosyltransferase. Glycobiology 2002;12:545-53
12. Sun J, Thurin J, Cooper HS, et al. Elevated expression of H type GDP-L-fucose: β-D-galactoside α-2-L-fucosyltransferase is associated with human colon adenocarcinoma progression. Proc Natl Acad Sci U S A 1995;92:5724-8
13. Orlow I, Lacombe L, Pellicer I, et al. Genotype and phenotypic characterization of the histoblood groups ABO(H) in primary bladder tumors. Int J Cancer 1998;75:819-24
14. Iwamoto S, Withers DA, Handa K, Hakomori S. Deletion of A-antigen in a human cancer cell line is associated with reduced promoter activity of CBF/NF-Y binding region, and possibly with enhanced DNA methylation of A transferase promoter. Glycoconjugate J 1999;16:659-66
15. Kominato Y, Hata Y, Takizawa H, Tsuchiya T, Tsukada J, Yamamoto F. Expression of human histo-blood group ABO genes is dependent upon DNA methylation of the promoter region. J Biol Chem 1999;274:37240-50
16. Gao S, Worm J, Guldberd P, et al. Genetic and epigenetic alteration of the blood group ABO gene in oral squamous cell carcinoma. Int J Cancer 2004;109:230-7
17. Ichikawa D, Handa K, Withers DA, Hakomori S. Histo-blood group A/B versus H status of human carcinoma cells as correlated with haptotactic cell motility: approach with A and B gene transfection. Cancer Res 1997;57:3092-6
18. Ichikawa D, Handa K, Hakomori S. Histo-blood group A/B antigen deletion/ reduction vs. continuous expression in human tumor cells as correlated with their malignancy. Int J Cancer 1998;76:284-9
19. Gao S, Bennett EP, Reibel J, et al. Histo-blood group ABO antigen in oral potentially malignant lesions and squamous cell carcinoma-genotypic and phenotypic characterization. APMIS 2004;112:11-20
20. Graziano SL, Tatum AH, Gonchoroff NJ, Newman NB, Kohman LJ. Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer. Clin Cancer Res 1997;3:87-93
21. Yazawa S, Takeya A, Hosomi O, et al. Use of synthetic H disaccharides as acceptors for detecting activities of UDP-GalNAc:Fuc αl→2Gal β-R α1→3-N-acetylgalactosaminyltransferase in plasma samples from blood group A subgroups. Clin Chem 1992;38:2392-5
22. Sobin LH, Wittekind C, eds. TNM: Classification of Malignant Tumours. 6th ed. New York: Wiley-Liss, 2002
23. Yazawa S, Madiyalakan R, Izawa H, et al. Cancer-associated elevation of α(l→3)-L-fucosyltransferase activity in human serum. Cancer 1988;62:516-520
24. Yazawa S, Asao T, Izawa H, et al. The presence of CA19-9 in serum and saliva from Lewis blood-group negative cancer patients. Jpn J Cancer Res 1988;79:538-43
25. Akamatsu S, Yazawa S, Zenita K, et al. Elevation of an α(l,3)fucosyltransferase activity correlated with apoptosis in human colon adenocarcinoma cell line, HT-29. Glycoconj J 1996;13:985-93
26. Nishihara S, Hiraga T, Ikehara Y, et al. Molecular mechanisms of expression of Lewis b antigen and other type 1 Lewis antigens in human colorectal cancer. Glycobiology 1999;9:607-16
27. Fujitani N, Liu Y, Toda S, et al. Expression of H type 1 antigen of ABO histo-blood group in normal colon and aberrant expressions of H type 2 and H type 3/4 antigens in colon cancer. Glycoconjugate J 2000;17:331-8
28. Hakomori S. Tumor malignancy of defined by aberrant glycosylation and sphingo-(glyco)lipid metabolism. Cancer Res 1996;56:5309-18
29. Lee JS, Ro JY, Sahin AA, et al. Expression of blood-group antigen-A-a favorable prognostic factor in non-small-cell lung cancer. N Engl J Med 1991;324:1084-90
30. Dabelsteen E. ABO blood group antigens in oral mucosa. What is new? J Oral Pathol Med 2002;31:65-70
31. Marionneau S, Le Moullac-Vaidve B, Le Pendu J. Expression of histo-blood group A antigen increases resistance to apoptosis and facilitates escape from immune control of rat colon carcinoma cells. Glycobiology 2002;12:851-6
32. Nakagoe T, Nanashima A, Sawai T, et al. Expression of blood group antigens A, B and H in carcinoma tissue correlates with a poor prognosis for colorectal cancer patients. J Cancer Res Clin Oncol 2000;126:375-82
33. Nakagoe T, Fukushima K, Nanashima A, et al. Comparison of the expression of ABH/Lewis-related antigens in polypoid and non-polypoid growth types of colorectal carcinoma. J Gastroenterol Hepatol 2001;16:176-83
34. Sakuma Y, Kubishiro K, Tsukazaki K, Nozawa S. Involvement of H type 1 carbohydrate antigen in cell adhesion to vascular endothelial cells of human endometrial cancer. Anticancer Res 2003;23:1277-82
35. x expression level in human pre-B lymphocytic leukemia cell line KM3 treated with phorbolester. J Biol Chem 1998;273:26779-89
36. Mathieu S, Prorol M, Benoliel A, et al. Transgene expression of α(l,2)-fucosyltransfease-I (FUT1) in tumor cells selectively inhibits sialyl-Lewis x expression and binding to E-selectin without affecting synthesis of sialyl-Lewis or binding to P-selecin. Am J Pathol 2004;164:371-83
37. Labarrière N, Pian JP, Otry C, et al. H blood group antigen carried by CD44V modulates tumorigenicity of rat colon carcinoma cells. Cancer Res 1994;54:6275-81
38. Goupille C, Hallouin F, Meflah K, Le Pendu J. Increase of rat colon carcinoma cells tumorigenicity by α(l-2)fucosyltransferase gene transfection. Glycobiology 1997;7:221-9
39. Hallouin F, Goupille C, Bureau V, Meflah K, Le Pendu J. Increased tumorigenicity of rat colon carcinoma cells after 2-fucosyltranferase FTA anti-sense cDNA transfection. Int J Cancer 1999;80:601-11
40. Cordel S, Goupille C, Hallouin F, et al. Role of α1, 2fucosyltransferase and histo-blood group H antigen type 2 in resistance of rat colon carcinoma cells to 5-fluorouracil. Int J Cancer 2000;85:142-8
41. Goupille C, Marionneau S, Bureau V, et al. α1,2Fucosyltransferase increases resistance to apoptosis of rat colon carcinoma cells. Glycobiology 2000;10:375-82
42. Zerfaoui M, Fukuda M, Sbarra V, Lombardo D, El-Battari A. α(l,2)-Fucosylation prevents sialyl Lewis x expression and E-selectin-mediated adhesion of fucosyltransferase VII-transfected cells. Eur J Biochem 2000;267:53-60
43. Chihara Y, Sugano K, Kobayashi A, et al. Loss of blood group A antigen expression in bladder cancer caused by allelic loss and/or methylation of the ABO gene. Lab Invest 2005;85:895-907